Iatrogenic Cushing's Syndrome After Topical Steroid Therapy for Psoriasis

Basit Öğe Kaydı
dc.authoridCelik, Mehmet/0000-0001-7364-370X
dc.authoridAytürk Salt, Semra/0000-0002-1560-3459
dc.authorwosidKüçükarda, Ahmet/AGF-2120-2022
dc.authorwosidCelik, Mehmet/AAA-8773-2021
dc.authorwosidAytürk Salt, Semra/U-4265-2017
dc.contributor.authorSahip, Birsen
dc.contributor.authorCelik, Mehmet
dc.contributor.authorAyturk, Semra
dc.contributor.authorKucukarda, Ahmet
dc.contributor.authorMert, Onur
dc.contributor.authorDincer, Nejla
dc.contributor.authorGuldiken, Sibel
dc.date.accessioned2024-06-12T11:03:38Z
dc.date.available2024-06-12T11:03:38Z
dc.date.issued2016
dc.departmentTrakya Üniversitesien_US
dc.description.abstractGlucocorticoids are used for the treatment of many diseases, such as inflammatory, allergic, autoimmune, and neoplastic diseases. They can be used in the form of topical, oral, inhalable, rectal, and intra-articular agents. Many topical steroid-related iatrogenic Cushing's syndrome cases affecting especially children have been reported in the literature. Topical steroid-related Cushing's syndrome is rarely seen in adults. In this report, we present the case of a 32-year-old male patient with iatrogenic Cushing's syndrome related to long-term clobetasol propionate treatment for psoriasis. In the context of such treatment, the glucocorticoid withdrawal problem has to be overcome. At present there is no consensus on steroid withdrawal. Patients on long-term glucocorticoid treatment must be evaluated for potential adverse effects and withdrawal symptoms by their physician and their endocrinologist.en_US
dc.identifier.doi10.4103/0019-5154.174094
dc.identifier.issn0019-5154
dc.identifier.issn1998-3611
dc.identifier.issue1en_US
dc.identifier.pmid26955131en_US
dc.identifier.scopus2-s2.0-85050337009en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.urihttps://doi.org/10.4103/0019-5154.174094
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21736
dc.identifier.volume61en_US
dc.identifier.wosWOS:000387597300049en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMedknow Publications & Media Pvt Ltden_US
dc.relation.ispartofIndian Journal Of Dermatologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectIatrogenic Cushing's Syndromeen_US
dc.subjectPsoriasisen_US
dc.subjectTopical Steroiden_US
dc.subjectGlucocorticoid Withdrawalen_US
dc.subjectCorticosteroidsen_US
dc.subjectSuppressionen_US
dc.subjectRecoveryen_US
dc.subjectTermen_US
dc.titleIatrogenic Cushing's Syndrome After Topical Steroid Therapy for Psoriasisen_US
dc.typeEditorialen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu